Tacrolimus Levels Are Not Associated with Risk of Malignancy in Lung Transplant Recipients

BACKGROUND: Lung transplant (LTx) recipients suffer from high rates of malignancy. Exposure to immunosuppressive medication such as tacrolimus has been proposed as a risk factor for tumorigenesis. We hypothesized that chronically high levels of tacrolimus would be associated with risk of malignancy....

Descripción completa

Detalles Bibliográficos
Autores principales: Fox, Benjamin Daniel, Ashquar, Fadi, Raviv, Yael, Rozengarten, Dror, Straichman, Osnat, Izhakian, Shimon, Kramer, Mordechai Reuven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2017
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6248030/
https://www.ncbi.nlm.nih.gov/pubmed/29133776
http://dx.doi.org/10.12659/AOT.904417

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6248030/
https://www.ncbi.nlm.nih.gov/pubmed/29133776
http://dx.doi.org/10.12659/AOT.904417

Ejemplares similares